Inari Medical
Stock Forecast, Prediction & Price Target

Inari Medical (NARI) stock Price Target by analysts

Last Year
Average Price Target

$63.5

Potential downside: -20.60%

Based on 6 analysts

Inari Medical price prediction

Strike.market

What is Inari Medical stock analysts` prediction?

Inari Medical stock forecast: Based on 6 Wall Street analysts` predicted price targets for Inari Medical in the last 3 months, the avarage price target is $63.5, with a high forecast of $NaN. The average price target represents a -20.60% change from the last price of $79.98.

Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.

Inari Medical stock Price Target by analysts

Full breakdown of analysts given Inari Medical price targets

Analyst name & company
Analyst win rate
Publish date
Price target
Price when posted
Source Historical targets
Richard Newitter
Truist Financial
0%
0/3
9 months ago $63 -21.22% downside $55.03 TheFly
Previous targets (2)
David Rescott
Robert W. Baird
0%
0/3
10 months ago $67 -16.22% downside $49.27 StreetInsider
Previous targets (2)
Adam Maeder
Piper Sandler
0%
0/2
10 months ago $52 -34.98% downside $42.56 TheFly
Previous targets (1)
Richard Newitter
Truist Financial
0%
0/3
10 months ago $50 -37.48% downside $42.56 StreetInsider
Previous targets (2)
Marie Thibault
BTIG
0%
0/1
10 months ago $86 7.52% upside $42.56 StreetInsider
Previous targets (0)
William Plovanic
Canaccord Genuity
0%
0/1
10 months ago $74 -7.47% downside $42.56 StreetInsider
Previous targets (0)
David Rescott
Robert W. Baird
0%
0/3
11 months ago $66 -17.47% downside $42.2 StreetInsider
Previous targets (2)
Mathew Blackman
Stifel Nicolaus
0%
0/1
12 months ago $50 -37.48% downside $44.1 TheFly
Previous targets (0)
Pito Chickering
Deutsche Bank
0%
0/1
about 1 year ago $68 -14.97% downside $48.72 StreetInsider
Previous targets (0)
David Rescott
Robert W. Baird
0%
0/3
about 1 year ago $63 -21.22% downside $52.11 TheFly
Previous targets (2)
Larry Biegelsen
Wells Fargo
0%
0/1
about 1 year ago $65 -18.72% downside $52.11 TheFly
Previous targets (0)
Richard Newitter
Truist Financial
0%
0/3
about 1 year ago $60 -24.97% downside $54.97 TheFly
Previous targets (2)
Adam Maeder
Piper Sandler
0%
0/2
over 1 year ago $50 -37.48% downside $44.3 StreetInsider
Previous targets (1)
Unknown
Morgan Stanley
N/A
over 2 years ago $83 3.77% upside $66.7 Benzinga
N/A
Unknown
Truist Financial
N/A
over 2 years ago $75 -6.22% downside $67.13 Benzinga
N/A
Unknown
Canaccord Genuity
N/A
almost 3 years ago $94 17.53% upside $68.65 Benzinga
N/A
Unknown
Morgan Stanley
N/A
about 3 years ago $93 16.28% upside $73.52 Benzinga
N/A
Unknown
BTIG
N/A
about 3 years ago $100 25.03% upside $72.32 Benzinga
N/A

Inari Medical Financial Estimates

Inari Medical Revenue Estimates

Inari Medical EBITDA Estimates

Inari Medical Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$276.98M
 
N/A
$383.47M
 
38.44%
$493.63M
 
28.72%
Avg: $705.43M
Low: $698.42M
High: $708.75M
avg. 42.90%
Avg: $824.70M
Low: $818.08M
High: $832.85M
avg. 16.90%
Avg: $1.00B
Low: $993.09M
High: $1.01B
avg. 21.39%
Avg: $1.15B
Low: $1.14B
High: $1.16B
avg. 15.34%
Net Income
 
% change YoY
$9.84M
 
N/A
$-29.26M
 
-397.42%
$-1.63M
 
94.41%
Avg: $8.21M
Low: $3.21M
High: $12.46M
avg. 602.11%
Avg: $28.58M
Low: $19.30M
High: $40.87M
avg. 247.91%
Avg: $55.82M
Low: $55.24M
High: $56.54M
avg. 95.32%
Avg: $94.23M
Low: $93.25M
High: $95.45M
avg. 68.81%
EBITDA
 
% change YoY
$10.98M
 
N/A
$-18.77M
 
-270.96%
$15.18M
 
180.90%
Avg: $22.72M
Low: $22.50M
High: $22.83M
avg. 49.66%
Avg: $26.57M
Low: $26.35M
High: $26.83M
avg. 16.90%
Avg: $32.25M
Low: $31.99M
High: $32.57M
avg. 21.39%
Avg: $37.20M
Low: $36.90M
High: $37.57M
avg. 15.34%
EPS
 
% change YoY
$0.2
 
N/A
-$0.55
 
-375%
-$0.03
 
94.76%
Avg: $0.14
Low: $0.06
High: $0.22
avg. 591.90%
Avg: $0.49
Low: $0.34
High: $0.72
avg. 243.05%
Avg: $0.98
Low: $0.97
High: $1
avg. 102.33%
Avg: $1.66
Low: $1.64
High: $1.68
avg. 68.81%
Operating Expenses
 
% change YoY
$241.38M
 
N/A
$367.06M
 
52.06%
$448.59M
 
22.21%
Avg: $496.57M
Low: $491.64M
High: $498.91M
avg. 10.69%
Avg: $580.53M
Low: $575.86M
High: $586.27M
avg. 16.90%
Avg: $704.72M
Low: $699.06M
High: $711.69M
avg. 21.39%
Avg: $812.89M
Low: $806.36M
High: $820.93M
avg. 15.34%

FAQ

What is Inari Medical stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 253.54% in 2025-2028.

We have gathered data from 6 analysts. Their low estimate is 3.21M, average is 8.21M and high is 12.46M.

What is Inari Medical stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 24.13% in 2025-2028.

We have gathered data from 8 analysts. Their low revenue estimate is $698.42M, average is $705.43M and high is $708.75M.

What is Inari Medical stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 251.52% in 2025-2028.

We have gathered data from 6 analysts. Their low earnings per share estimate is $0.06, average is $0.14 and high is $0.21.

What is the best performing analyst?

In the last twelve months 6 analysts have been covering Inari Medical stock. The most successful analyst is Richard Newitter.